Posts

Showing posts with the label Breast Cancer

Breast Cancer Surgeries in (COVID - 19) Pandemic

Image
  Abstract The aim of this study is to provide an insight into the impact of COVID-19 pandemic on the breast cancer surgical field in our setup. We will summarize the protection measures adapted over the time span of COVID-19 pandemic. We will also discuss the decision to prioritize patients based on tumor biology, stage and phase of treatment, and the effects of COVID-19 on patients in terms of morbidity and death. In addition, we are going to discuss new approaches of communication between patients and healthcare workers. Keywords : Breast surgical (surgery or surgical procedure) – Prioritizing sufferers –COVID-19pandemic–Tumor biology –Morbidity and mortality –Communication Introduction A significant concern has risen around the globe due to the corona virus disease regarding healthcare safety. Curfews, social distancing and health facility avoidance have reduced routine controls and screening programs (Yao, K. A. 2020). Patients with breast cancer are more likely to e...

CANCER BREAKTHROUGH: Programmable Self-Regulated Nano Transporters

Image
Cancer might be a disease from the past couple of centuries, but only the technology to cure it has only been starting to develop these days. With such innovations, many cancers are highly probable of being cured, if diagnosed early, meaning higher chances for cancer patients to live longer.   The cancer epidemic is one of the crucial global health issues, at present, accounting for around 10 million deaths every year. In 2022, studies estimated about 1.9 million incidents and 609,360 deaths will be reported from malignancy in the United States, alone [1] . Luckily, preventative measures are accessible. Around 30-50% of all cancer cases are currently preventable through a series of procedures to avoid or reduce exposure to risk factors, such as smoking cessation programs for smokers [2] . The number of cancer patients who survived through traditional clinical therapies was just about 25%, which has now improved to nearly 50% [3] . As a result, targeted therapy is now a cur...